SETA trial

• Conditions: Anxiety disordersSelf-esteemAngststoornissenZelfbeeldZelfwaardering

• Registration Number: NL-OMON26034
• Lead Sponsor: niversity of Utrecht, The Netherlands. Prof. Dr. I Engelhard.

Brief Summary

o publications of this trial yet. We will aim to publish the outcome of the trial in an English journal. Our current research group has experience and publications on this particular topic however, e.g. by Prof. Dr. I. Engelhard and Dr. C.W. Korrelboom.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

People with a primary anxiety disorder according to the DSM-IV, possibly more than one anxiety disorder, co-morbid depression and/or other co-morbid symptoms. So co-morbidity is not an exclusion criterion.

Further inclusion criteria are:
–An anxiety disorder, based on a structured DSM-IV interview
–Low self-esteem (< 26 on the Rosenberg Self-esteem scale)
–For one month or more: no changes in psychopharmacological medications
–Mastery of the Dutch language, in order to be able to fill out the questionnaires
–Able to mention at least one positive aspect within his/her self-image, which does not need to be felt or be completely convincing

At Altrecht psychiatric institute, there is an extra inclusion criterion: the anxiety disorder has been treated for at least 12 sessions with regular evidence-based therapy. Despite this, anxiety symptoms are still present in the psychopathological level, as shows by scoring 39 or higher on the state part of the STAI instrument (Julian, 2011). Thus, the disorder has not responded well enough to regular treatment. At the other participating institution, PsyQ, this criterion is not applied. There, patients may participate in the study right after intake procedure. This difference is a consequence of available patients groups and the vision of therapists and researchers of both institutions. However, despite the fact that the selected patient groups will not be completely comparable, a broader population will enter the study this way, which has benefits. And it is not the goal to compare the two institutions.

Exclusion Criteria

–Drug abuse or dependance according to DSM-IV criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified